Nuclear medicine methods in the diagnosis of cardiovascular illnesses
Authors:
J. Bakala
Published in:
Kardiol Rev Int Med 2007, 9(3): 170-176
Overview
The article deals with non-invasive nuclear medicine methods used to diagnose heart problems in ICHS. These include Single Photon Emission Computed Tomography (SPECT) myocardial perfusion scans and gated SPECT of the myocardium with a calculation of the objective values for the ejection fraction and monitoring of changes in kinetics at rest and under load. It goes on to offer options for the diagnosis of cardiac autonomic neuropathy or of cardiac failure through the use of 123I-MIBG (m-iodobenzylguanidine) using the SPECT method. In their conclusion the authors examine the emerging techniques that are certain to influence physicians and patients in the future, including percutaneous transluminal coronary angioplasty (PTCA), computer tomography combined with SPECT, positron emission tomography/computed tomography (PET/CT) and also the use of telemedicine and the PACS system (Picture Archiving and Communications System) not only in diagnosis, but also in e-learning for patient education.
Keywords:
perfusion scintography of the myocardium SPECT-SPECT/CT-PET/CT-123I MIBG
Sources
1. Marcassa C, Delaloye AB, Cuocolo A et al. The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology. Eur J Nucl Med 2006; 33(12): 1509–1512.
2. Adamikova A, Bakala J, Bernatek J, Rybka J, Svacina S. Transient ischemic ditation ratio(TID) correlates with HbA1c in patients with diabetes type 2 with proven myocardial ischemia according to exercise myocardial SPECT. Ann Nucl Med 2006; 20(9): 615–621.
3. Biagini E, Shaw LJ, Poldermans D et al. Accuracy of non–invasive techniques for diagnostic of coronary artery disease and prediction of cardiac events in patients with left bundle branch bloch: a meta–analysis. Eur J Nucl Med 2006; 33(12): 1442–1451.
4. Wiersma JJ, Verberne HJ, Trip MD et al. Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms. Eur J Nucl Med 2006; 33(12): 1468–1476.
5. Noble GL, Heller GV. Single–photon Emission Computed Tomography Myocardial Perfusion Imagnig in Patients with Diabetic. Curr Cardiol Rep 2005; 7(2): 117–123.
6. Rajagopalan N, Miller TD, Hodge DO et al. Identifying high–risk asymptomatic diabetic patients who are candidates for screening stress single–photon emission computed tomography imaging. J Am Coll Cardiol 2005; 45: 43–49.
7. Ritchie JL, Bateman TM, Bonow RO et al. ACC/AHA Task Force report Giudelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Committee on Radionuclide Imaging): developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 1995; 25: 521–547.
8. Gokcel A, Aydin M, Yalcin F et al. Silent coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol 2003; 40(4): 176–180.
9. Basoglu T, Coskun C, Bernay T et al. Myocardial perfusion SPECT imaging with Tc–99m–Tetrofosmin in type II diabetes mellitus patients: A comparison to Tl–201 SPECT, preliminary results. Eur J Nucl Med 1996; 23(9): 1027–1028. EANM Copenhagen Poster Presentation.
10. Abdulnabi T, Mahussain SA, Sadanandan S. Cardiac tests in asymptomatic type diabetics. Med Princ Prac 2002; 11(4): 171–175.
11. Trease L, van Every B, Bennel K et al. A prospective blinded evaluation of exercise thallium–201 SPET in patients with suspected chronic exertional compartment syndrome of the leg. Eur J Nucl Med 2001; 28(6): 688–695.
12. Cerqueira MD. Myocardial Perfusion Imaging: Role in Prognosis, Future Applications. http://www.medscape.com/viewprogram/1806.
13. Abidov A, Berman D. Transient ischemic dilation associated with poststress myocardial stunning of the left ventricle in vasodilator stress myocardial perfusion SPECT: True marker of severe ischemia? J Nucl Cardiol 2005; 12(3): 258–260.
14. Bonow R. O, Bohannon N, Hazzard W. Risk stratification in coronary artery disease and special populations. Am J Med 1996; 101(Suppl): 17–22.
15. Khaleeli E, Peters SR, Bobrowsky K et al. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: implications for management. Am Heart J 2001; 141: 637–644.
16. Kang X, Berman DS, Lewin HC et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999; 138: 1025–1032.
17. Nesto RW, Phillips RT, Kett KG et al. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988; 108: 170–175.
18. Hachamovitch R, Berman DS, Kiat H et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905–914.
19. Sasao H, Nakata T, Tsuchihashi K et al. Impaired exercise–related myocardial uptake of technetium–99m–tetrofosmin in relation to coronary narrowing and diabetic state: Assessment with quantitative single photon emission computed tomography. Jpn Heart J 2001; 42(1): 29–42.
20. Germano G. Clinical Gated Cardiac SPECT. New York: Futura Publishing 1999.
21. Germano G, Kiat H, Kavanagh et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36(11): 2138–2147.
22. Petix NR, Sestini S, Coppola A et al. Prognostic Value of Combined Perfusion and Function by Stress Technetium–99mSestamibi Gated SPECT Myocardial Perfusion Imaging in Patients With Suspected or Known Coronary Artery Disease. Am J of Cardiology 2005; 95(11): 1351–1387.
23. Pena H, Guilhermina G, Machado AP et al. Risk factors and coronary artery disease in myocardial perfusion gated. J Nucl Cardiol 2003; Part 2 , 10 (1) PROSÍM AUTORA O DOPLNĚNÍ STRÁNKOVÉHO ROZSAHU
24. Belch JJF, Topol EJ, Agnelli G et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 884–892.
25. Giordano A, Calcagni ML, Verrillo A et al. Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I–MIBG. Diabetes Nutr Metab 2000; 13(6): 350–355.
26. Machac J. Conventional, Metabolic, and Neuroendocrine Imaging in the Selection of Patients for Bypass vs. Transplant Surgery. 1 st Virtual Congres of Cardiology 2003.PROSÍM AUTORA O DOPLNĚNÍ, KDY SE KONGRES KONAL, EVENT. WEBOVÉ STRÁNKY
27. Bengel FM, Permanetter B, Ungerer M et al. Alternation of the sympathetic nervous system and metabolic performance of the cardiomyopathic heart. Eur J Nucl Med 2002; 29(2): 198–202.
28. Marini C, Giorgetti A, Gimelli A et al. Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy. Eur J Nucl Med 2005; 32(6): 682–688.
29. Scott LA, Kench PL. Cardiac Autonomic Neuropatjy in the Diabetic Patient: Does 123I–MIBG Imaging Have a Role to Play in Early Diagnosis? J Nucl Med Technol 2004; 32(2): 66–71.
30. Tolar V. Význam vyšetřování zdravých pro prevenci. Prakt lék 1936; 16: PROSÍM AUTORA O DOPLNĚNÍ STRÁNKOVÉHO ROZSAHU
31. Lucignani G. Data acquisition and analysis: the strenght of methodology in nuclear medicine and molecular imaging. Eur J Nucl Med 2006; 33(12): 1513–1516.
32. Lucignani G. PET/CT in cardiology: an area whose boundaries are still out of sihgt. Eur J Nucl Med 2006; 33(5): 622–623.
Labels
Paediatric cardiology Internal medicine Cardiac surgery CardiologyArticle was published in
Cardiology Review
2007 Issue 3
Most read in this issue
- Monitoring peroral anticoagulation therapy in outpatient practice
- Importance of implantable loop recorder in patients with unexplaided syncope
- CURRENT MEDICAL LITERATURE LTD, LONDON 1998, 438S.
- Pulmonary arterial hypertension